Standard Versus Double Dose Dolutegravir in Patients With HIV-associated Tuberculosis
Clinical trial NCT03851588 · COMPLETED
Trial details
- NCT number
- NCT03851588
- Sponsor
- University of Cape Town
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-19
- Primary completion
- 2022-01-20
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.